Sari Hopson
About Sari Hopson
Company
Sari Hopson currently works at Bristol Myers Squibb, serving as Director of Pharmacoepidemiology. Known for its innovative medicines, Bristol Myers Squibb focuses on numerous therapeutic areas, including oncology, cardiovascular, immunology, and fibrosis.
Title
Sari Hopson holds the role of Director Pharmacoepidemiology at Bristol Myers Squibb. She started this position in May 2021 and is responsible for real-world evidence research to address healthcare and market challenges.
Education and Expertise
Sari Hopson earned her Doctor of Philosophy (PhD) and Master of Science in Public Health (MSPH) in Epidemiology from Emory University. She also holds a Bachelor of Science in Public Health in Biostatistics and a Bachelor of Arts in Biology from UNC Chapel Hill. Her expertise lies in real-world evidence research, leveraging database analyses to understand healthcare and market challenges.
Background
Sari Hopson began her career at the Southeastern Kidney Council as an Epidemiologist from 2005 to 2007. She then served as a Statistical Consultant at Emory University’s School of Medicine in the Center for Injury Control from 2010 to 2011. At Humana, she worked as a Consumer Analyst and Research Scientist/Research Consultant for nearly six years. Further roles included an Associate Director at Xcenda and a Data Scientist at UCB before her current position at Bristol Myers Squibb.
Achievements
Sari Hopson brings strong conceptual and analytical skills to her roles, focusing on identifying solutions to healthcare challenges. She has extensive experience in real-world evidence research, which is utilized to address payer and pharmaceutical client needs through comprehensive database analyses.